 | • レポートコード：MRC2-11QY05787 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエスシタロプラムのグローバル市場について調査・分析したレポートです。種類別（溶液、錠剤、その他）市場規模、用途別（病院・診療所、個人用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エスシタロプラムの競争状況、市場シェア ・世界のエスシタロプラム市場：種類別市場規模 2015年-2020年（溶液、錠剤、その他） ・世界のエスシタロプラム市場：種類別市場規模予測 2021年-2026年（溶液、錠剤、その他） ・世界のエスシタロプラム市場：用途別市場規模 2015年-2020年（病院・診療所、個人用、その他） ・世界のエスシタロプラム市場：用途別市場規模予測 2021年-2026年（病院・診療所、個人用、その他） ・北米のエスシタロプラム市場分析：米国、カナダ ・ヨーロッパのエスシタロプラム市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエスシタロプラム市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエスシタロプラム市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエスシタロプラム市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Forest Laboratories(US)、H.Lundbeck A/S(DK)、Amneal Pharmaceuticals(US)、Aurobindo Pharma(IN)、Hetero Drugs(IN)、Macleods Pharmaceuticals(IN)、Silarx Pharmacueticals(US)、Apotex(CA)、Hikma Pharmaceuticals(UK)、Jubilant Pharma(SG)、Lupin Limited(IN)、Prinston Pharmaceutical(US)、STI Pharma(US)、TEVA Pharmaceutical(US) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Escitalopram Market
The global Escitalopram market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Escitalopram Scope and Market Size
Escitalopram market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Escitalopram market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Escitalopram market is segmented into
Solution
Tablet
Others
Segment by Application, the Escitalopram market is segmented into
Hospitals and Clinics
Individual Use
Others
Regional and Country-level Analysis
The Escitalopram market is analysed and market size information is provided by regions (countries).
The key regions covered in the Escitalopram market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Escitalopram Market Share Analysis
Escitalopram market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Escitalopram business, the date to enter into the Escitalopram market, Escitalopram product introduction, recent developments, etc.
The major vendors covered:
Forest Laboratories(US)
H.Lundbeck A/S(DK)
Amneal Pharmaceuticals(US)
Aurobindo Pharma(IN)
Hetero Drugs(IN)
Macleods Pharmaceuticals(IN)
Silarx Pharmacueticals(US)
Apotex(CA)
Hikma Pharmaceuticals(UK)
Jubilant Pharma(SG)
Lupin Limited(IN)
Prinston Pharmaceutical(US)
STI Pharma(US)
TEVA Pharmaceutical(US)
1 Study Coverage
1.1 Escitalopram Product Introduction
1.2 Market Segments
1.3 Key Escitalopram Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Escitalopram Market Size Growth Rate by Type
1.4.2 Solution
1.4.3 Tablet
1.4.4 Others
1.5 Market by Application
1.5.1 Global Escitalopram Market Size Growth Rate by Application
1.5.2 Hospitals and Clinics
1.5.3 Individual Use
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Escitalopram Market Size, Estimates and Forecasts
2.1.1 Global Escitalopram Revenue 2015-2026
2.1.2 Global Escitalopram Sales 2015-2026
2.2 Global Escitalopram, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Escitalopram Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Escitalopram Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Escitalopram Competitor Landscape by Players
3.1 Escitalopram Sales by Manufacturers
3.1.1 Escitalopram Sales by Manufacturers (2015-2020)
3.1.2 Escitalopram Sales Market Share by Manufacturers (2015-2020)
3.2 Escitalopram Revenue by Manufacturers
3.2.1 Escitalopram Revenue by Manufacturers (2015-2020)
3.2.2 Escitalopram Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Escitalopram Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Escitalopram Revenue in 2019
3.2.5 Global Escitalopram Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Escitalopram Price by Manufacturers
3.4 Escitalopram Manufacturing Base Distribution, Product Types
3.4.1 Escitalopram Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Escitalopram Product Type
3.4.3 Date of International Manufacturers Enter into Escitalopram Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Escitalopram Market Size by Type (2015-2020)
4.1.1 Global Escitalopram Sales by Type (2015-2020)
4.1.2 Global Escitalopram Revenue by Type (2015-2020)
4.1.3 Escitalopram Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Escitalopram Market Size Forecast by Type (2021-2026)
4.2.1 Global Escitalopram Sales Forecast by Type (2021-2026)
4.2.2 Global Escitalopram Revenue Forecast by Type (2021-2026)
4.2.3 Escitalopram Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Escitalopram Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Escitalopram Market Size by Application (2015-2020)
5.1.1 Global Escitalopram Sales by Application (2015-2020)
5.1.2 Global Escitalopram Revenue by Application (2015-2020)
5.1.3 Escitalopram Price by Application (2015-2020)
5.2 Escitalopram Market Size Forecast by Application (2021-2026)
5.2.1 Global Escitalopram Sales Forecast by Application (2021-2026)
5.2.2 Global Escitalopram Revenue Forecast by Application (2021-2026)
5.2.3 Global Escitalopram Price Forecast by Application (2021-2026)
6 North America
6.1 North America Escitalopram by Country
6.1.1 North America Escitalopram Sales by Country
6.1.2 North America Escitalopram Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Escitalopram Market Facts & Figures by Type
6.3 North America Escitalopram Market Facts & Figures by Application
7 Europe
7.1 Europe Escitalopram by Country
7.1.1 Europe Escitalopram Sales by Country
7.1.2 Europe Escitalopram Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Escitalopram Market Facts & Figures by Type
7.3 Europe Escitalopram Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Escitalopram by Region
8.1.1 Asia Pacific Escitalopram Sales by Region
8.1.2 Asia Pacific Escitalopram Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Escitalopram Market Facts & Figures by Type
8.3 Asia Pacific Escitalopram Market Facts & Figures by Application
9 Latin America
9.1 Latin America Escitalopram by Country
9.1.1 Latin America Escitalopram Sales by Country
9.1.2 Latin America Escitalopram Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Escitalopram Market Facts & Figures by Type
9.3 Central & South America Escitalopram Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Escitalopram by Country
10.1.1 Middle East and Africa Escitalopram Sales by Country
10.1.2 Middle East and Africa Escitalopram Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Escitalopram Market Facts & Figures by Type
10.3 Middle East and Africa Escitalopram Market Facts & Figures by Application
11 Company Profiles
11.1 Forest Laboratories(US)
11.1.1 Forest Laboratories(US) Corporation Information
11.1.2 Forest Laboratories(US) Description and Business Overview
11.1.3 Forest Laboratories(US) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Forest Laboratories(US) Escitalopram Products Offered
11.1.5 Forest Laboratories(US) Related Developments
11.2 H.Lundbeck A/S(DK)
11.2.1 H.Lundbeck A/S(DK) Corporation Information
11.2.2 H.Lundbeck A/S(DK) Description and Business Overview
11.2.3 H.Lundbeck A/S(DK) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 H.Lundbeck A/S(DK) Escitalopram Products Offered
11.2.5 H.Lundbeck A/S(DK) Related Developments
11.3 Amneal Pharmaceuticals(US)
11.3.1 Amneal Pharmaceuticals(US) Corporation Information
11.3.2 Amneal Pharmaceuticals(US) Description and Business Overview
11.3.3 Amneal Pharmaceuticals(US) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Amneal Pharmaceuticals(US) Escitalopram Products Offered
11.3.5 Amneal Pharmaceuticals(US) Related Developments
11.4 Aurobindo Pharma(IN)
11.4.1 Aurobindo Pharma(IN) Corporation Information
11.4.2 Aurobindo Pharma(IN) Description and Business Overview
11.4.3 Aurobindo Pharma(IN) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Aurobindo Pharma(IN) Escitalopram Products Offered
11.4.5 Aurobindo Pharma(IN) Related Developments
11.5 Hetero Drugs(IN)
11.5.1 Hetero Drugs(IN) Corporation Information
11.5.2 Hetero Drugs(IN) Description and Business Overview
11.5.3 Hetero Drugs(IN) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Hetero Drugs(IN) Escitalopram Products Offered
11.5.5 Hetero Drugs(IN) Related Developments
11.6 Macleods Pharmaceuticals(IN)
11.6.1 Macleods Pharmaceuticals(IN) Corporation Information
11.6.2 Macleods Pharmaceuticals(IN) Description and Business Overview
11.6.3 Macleods Pharmaceuticals(IN) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Macleods Pharmaceuticals(IN) Escitalopram Products Offered
11.6.5 Macleods Pharmaceuticals(IN) Related Developments
11.7 Silarx Pharmacueticals(US)
11.7.1 Silarx Pharmacueticals(US) Corporation Information
11.7.2 Silarx Pharmacueticals(US) Description and Business Overview
11.7.3 Silarx Pharmacueticals(US) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Silarx Pharmacueticals(US) Escitalopram Products Offered
11.7.5 Silarx Pharmacueticals(US) Related Developments
11.8 Apotex(CA)
11.8.1 Apotex(CA) Corporation Information
11.8.2 Apotex(CA) Description and Business Overview
11.8.3 Apotex(CA) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Apotex(CA) Escitalopram Products Offered
11.8.5 Apotex(CA) Related Developments
11.9 Hikma Pharmaceuticals(UK)
11.9.1 Hikma Pharmaceuticals(UK) Corporation Information
11.9.2 Hikma Pharmaceuticals(UK) Description and Business Overview
11.9.3 Hikma Pharmaceuticals(UK) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hikma Pharmaceuticals(UK) Escitalopram Products Offered
11.9.5 Hikma Pharmaceuticals(UK) Related Developments
11.10 Jubilant Pharma(SG)
11.10.1 Jubilant Pharma(SG) Corporation Information
11.10.2 Jubilant Pharma(SG) Description and Business Overview
11.10.3 Jubilant Pharma(SG) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Jubilant Pharma(SG) Escitalopram Products Offered
11.10.5 Jubilant Pharma(SG) Related Developments
11.1 Forest Laboratories(US)
11.1.1 Forest Laboratories(US) Corporation Information
11.1.2 Forest Laboratories(US) Description and Business Overview
11.1.3 Forest Laboratories(US) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Forest Laboratories(US) Escitalopram Products Offered
11.1.5 Forest Laboratories(US) Related Developments
11.12 Prinston Pharmaceutical(US)
11.12.1 Prinston Pharmaceutical(US) Corporation Information
11.12.2 Prinston Pharmaceutical(US) Description and Business Overview
11.12.3 Prinston Pharmaceutical(US) Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Prinston Pharmaceutical(US) Products Offered
11.12.5 Prinston Pharmaceutical(US) Related Developments
11.13 STI Pharma(US)
11.13.1 STI Pharma(US) Corporation Information
11.13.2 STI Pharma(US) Description and Business Overview
11.13.3 STI Pharma(US) Sales, Revenue and Gross Margin (2015-2020)
11.13.4 STI Pharma(US) Products Offered
11.13.5 STI Pharma(US) Related Developments
11.14 TEVA Pharmaceutical(US)
11.14.1 TEVA Pharmaceutical(US) Corporation Information
11.14.2 TEVA Pharmaceutical(US) Description and Business Overview
11.14.3 TEVA Pharmaceutical(US) Sales, Revenue and Gross Margin (2015-2020)
11.14.4 TEVA Pharmaceutical(US) Products Offered
11.14.5 TEVA Pharmaceutical(US) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Escitalopram Market Estimates and Projections by Region
12.1.1 Global Escitalopram Sales Forecast by Regions 2021-2026
12.1.2 Global Escitalopram Revenue Forecast by Regions 2021-2026
12.2 North America Escitalopram Market Size Forecast (2021-2026)
12.2.1 North America: Escitalopram Sales Forecast (2021-2026)
12.2.2 North America: Escitalopram Revenue Forecast (2021-2026)
12.2.3 North America: Escitalopram Market Size Forecast by Country (2021-2026)
12.3 Europe Escitalopram Market Size Forecast (2021-2026)
12.3.1 Europe: Escitalopram Sales Forecast (2021-2026)
12.3.2 Europe: Escitalopram Revenue Forecast (2021-2026)
12.3.3 Europe: Escitalopram Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Escitalopram Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Escitalopram Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Escitalopram Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Escitalopram Market Size Forecast by Region (2021-2026)
12.5 Latin America Escitalopram Market Size Forecast (2021-2026)
12.5.1 Latin America: Escitalopram Sales Forecast (2021-2026)
12.5.2 Latin America: Escitalopram Revenue Forecast (2021-2026)
12.5.3 Latin America: Escitalopram Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Escitalopram Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Escitalopram Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Escitalopram Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Escitalopram Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Escitalopram Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Escitalopram Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Escitalopram Market Segments
Table 2. Ranking of Global Top Escitalopram Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Escitalopram Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Solution
Table 5. Major Manufacturers of Tablet
Table 6. Major Manufacturers of Others
Table 7. Global Escitalopram Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Escitalopram Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Escitalopram Sales by Regions 2015-2020 (K Units)
Table 10. Global Escitalopram Sales Market Share by Regions (2015-2020)
Table 11. Global Escitalopram Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Escitalopram Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Escitalopram Sales Share by Manufacturers (2015-2020)
Table 14. Global Escitalopram Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Escitalopram by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Escitalopram as of 2019)
Table 16. Escitalopram Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Escitalopram Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Escitalopram Price (2015-2020) (USD/Unit)
Table 19. Escitalopram Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Escitalopram Product Type
Table 21. Date of International Manufacturers Enter into Escitalopram Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Escitalopram Sales by Type (2015-2020) (K Units)
Table 24. Global Escitalopram Sales Share by Type (2015-2020)
Table 25. Global Escitalopram Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Escitalopram Revenue Share by Type (2015-2020)
Table 27. Escitalopram Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Escitalopram Sales by Application (2015-2020) (K Units)
Table 29. Global Escitalopram Sales Share by Application (2015-2020)
Table 30. North America Escitalopram Sales by Country (2015-2020) (K Units)
Table 31. North America Escitalopram Sales Market Share by Country (2015-2020)
Table 32. North America Escitalopram Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Escitalopram Revenue Market Share by Country (2015-2020)
Table 34. North America Escitalopram Sales by Type (2015-2020) (K Units)
Table 35. North America Escitalopram Sales Market Share by Type (2015-2020)
Table 36. North America Escitalopram Sales by Application (2015-2020) (K Units)
Table 37. North America Escitalopram Sales Market Share by Application (2015-2020)
Table 38. Europe Escitalopram Sales by Country (2015-2020) (K Units)
Table 39. Europe Escitalopram Sales Market Share by Country (2015-2020)
Table 40. Europe Escitalopram Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Escitalopram Revenue Market Share by Country (2015-2020)
Table 42. Europe Escitalopram Sales by Type (2015-2020) (K Units)
Table 43. Europe Escitalopram Sales Market Share by Type (2015-2020)
Table 44. Europe Escitalopram Sales by Application (2015-2020) (K Units)
Table 45. Europe Escitalopram Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Escitalopram Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Escitalopram Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Escitalopram Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Escitalopram Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Escitalopram Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Escitalopram Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Escitalopram Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Escitalopram Sales Market Share by Application (2015-2020)
Table 54. Latin America Escitalopram Sales by Country (2015-2020) (K Units)
Table 55. Latin America Escitalopram Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Escitalopram Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Escitalopram Revenue Market Share by Country (2015-2020)
Table 58. Latin America Escitalopram Sales by Type (2015-2020) (K Units)
Table 59. Latin America Escitalopram Sales Market Share by Type (2015-2020)
Table 60. Latin America Escitalopram Sales by Application (2015-2020) (K Units)
Table 61. Latin America Escitalopram Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Escitalopram Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Escitalopram Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Escitalopram Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Escitalopram Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Escitalopram Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Escitalopram Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Escitalopram Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Escitalopram Sales Market Share by Application (2015-2020)
Table 70. Forest Laboratories(US) Corporation Information
Table 71. Forest Laboratories(US) Description and Major Businesses
Table 72. Forest Laboratories(US) Escitalopram Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Forest Laboratories(US) Product
Table 74. Forest Laboratories(US) Recent Development
Table 75. H.Lundbeck A/S(DK) Corporation Information
Table 76. H.Lundbeck A/S(DK) Description and Major Businesses
Table 77. H.Lundbeck A/S(DK) Escitalopram Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. H.Lundbeck A/S(DK) Product
Table 79. H.Lundbeck A/S(DK) Recent Development
Table 80. Amneal Pharmaceuticals(US) Corporation Information
Table 81. Amneal Pharmaceuticals(US) Description and Major Businesses
Table 82. Amneal Pharmaceuticals(US) Escitalopram Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Amneal Pharmaceuticals(US) Product
Table 84. Amneal Pharmaceuticals(US) Recent Development
Table 85. Aurobindo Pharma(IN) Corporation Information
Table 86. Aurobindo Pharma(IN) Description and Major Businesses
Table 87. Aurobindo Pharma(IN) Escitalopram Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Aurobindo Pharma(IN) Product
Table 89. Aurobindo Pharma(IN) Recent Development
Table 90. Hetero Drugs(IN) Corporation Information
Table 91. Hetero Drugs(IN) Description and Major Businesses
Table 92. Hetero Drugs(IN) Escitalopram Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Hetero Drugs(IN) Product
Table 94. Hetero Drugs(IN) Recent Development
Table 95. Macleods Pharmaceuticals(IN) Corporation Information
Table 96. Macleods Pharmaceuticals(IN) Description and Major Businesses
Table 97. Macleods Pharmaceuticals(IN) Escitalopram Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Macleods Pharmaceuticals(IN) Product
Table 99. Macleods Pharmaceuticals(IN) Recent Development
Table 100. Silarx Pharmacueticals(US) Corporation Information
Table 101. Silarx Pharmacueticals(US) Description and Major Businesses
Table 102. Silarx Pharmacueticals(US) Escitalopram Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Silarx Pharmacueticals(US) Product
Table 104. Silarx Pharmacueticals(US) Recent Development
Table 105. Apotex(CA) Corporation Information
Table 106. Apotex(CA) Description and Major Businesses
Table 107. Apotex(CA) Escitalopram Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Apotex(CA) Product
Table 109. Apotex(CA) Recent Development
Table 110. Hikma Pharmaceuticals(UK) Corporation Information
Table 111. Hikma Pharmaceuticals(UK) Description and Major Businesses
Table 112. Hikma Pharmaceuticals(UK) Escitalopram Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Hikma Pharmaceuticals(UK) Product
Table 114. Hikma Pharmaceuticals(UK) Recent Development
Table 115. Jubilant Pharma(SG) Corporation Information
Table 116. Jubilant Pharma(SG) Description and Major Businesses
Table 117. Jubilant Pharma(SG) Escitalopram Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Jubilant Pharma(SG) Product
Table 119. Jubilant Pharma(SG) Recent Development
Table 120. Lupin Limited(IN) Corporation Information
Table 121. Lupin Limited(IN) Description and Major Businesses
Table 122. Lupin Limited(IN) Escitalopram Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Lupin Limited(IN) Product
Table 124. Lupin Limited(IN) Recent Development
Table 125. Prinston Pharmaceutical(US) Corporation Information
Table 126. Prinston Pharmaceutical(US) Description and Major Businesses
Table 127. Prinston Pharmaceutical(US) Escitalopram Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Prinston Pharmaceutical(US) Product
Table 129. Prinston Pharmaceutical(US) Recent Development
Table 130. STI Pharma(US) Corporation Information
Table 131. STI Pharma(US) Description and Major Businesses
Table 132. STI Pharma(US) Escitalopram Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. STI Pharma(US) Product
Table 134. STI Pharma(US) Recent Development
Table 135. TEVA Pharmaceutical(US) Corporation Information
Table 136. TEVA Pharmaceutical(US) Description and Major Businesses
Table 137. TEVA Pharmaceutical(US) Escitalopram Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. TEVA Pharmaceutical(US) Product
Table 139. TEVA Pharmaceutical(US) Recent Development
Table 140. Global Escitalopram Sales Forecast by Regions (2021-2026) (K Units)
Table 141. Global Escitalopram Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Escitalopram Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Escitalopram Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Escitalopram Sales Forecast by Country (2021-2026) (K Units)
Table 145. North America: Escitalopram Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Escitalopram Sales Forecast by Country (2021-2026) (K Units)
Table 147. Europe: Escitalopram Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Escitalopram Sales Forecast by Region (2021-2026) (K Units)
Table 149. Asia Pacific: Escitalopram Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Escitalopram Sales Forecast by Country (2021-2026) (K Units)
Table 151. Latin America: Escitalopram Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Escitalopram Sales Forecast by Country (2021-2026) (K Units)
Table 153. Middle East and Africa: Escitalopram Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Escitalopram Players
Table 158. Escitalopram Customers List
Table 159. Escitalopram Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Escitalopram Product Picture
Figure 2. Global Escitalopram Sales Market Share by Type in 2020 & 2026
Figure 3. Solution Product Picture
Figure 4. Tablet Product Picture
Figure 5. Others Product Picture
Figure 6. Global Escitalopram Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals and Clinics
Figure 8. Individual Use
Figure 9. Others
Figure 10. Escitalopram Report Years Considered
Figure 11. Global Escitalopram Market Size 2015-2026 (US$ Million)
Figure 12. Global Escitalopram Sales 2015-2026 (K Units)
Figure 13. Global Escitalopram Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Escitalopram Sales Market Share by Region (2015-2020)
Figure 15. Global Escitalopram Sales Market Share by Region in 2019
Figure 16. Global Escitalopram Revenue Market Share by Region (2015-2020)
Figure 17. Global Escitalopram Revenue Market Share by Region in 2019
Figure 18. Global Escitalopram Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Escitalopram Revenue in 2019
Figure 20. Escitalopram Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Escitalopram Sales Market Share by Type (2015-2020)
Figure 22. Global Escitalopram Sales Market Share by Type in 2019
Figure 23. Global Escitalopram Revenue Market Share by Type (2015-2020)
Figure 24. Global Escitalopram Revenue Market Share by Type in 2019
Figure 25. Global Escitalopram Market Share by Price Range (2015-2020)
Figure 26. Global Escitalopram Sales Market Share by Application (2015-2020)
Figure 27. Global Escitalopram Sales Market Share by Application in 2019
Figure 28. Global Escitalopram Revenue Market Share by Application (2015-2020)
Figure 29. Global Escitalopram Revenue Market Share by Application in 2019
Figure 30. North America Escitalopram Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Escitalopram Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Escitalopram Sales Market Share by Country in 2019
Figure 33. North America Escitalopram Revenue Market Share by Country in 2019
Figure 34. U.S. Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Escitalopram Market Share by Type in 2019
Figure 39. North America Escitalopram Market Share by Application in 2019
Figure 40. Europe Escitalopram Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Escitalopram Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Escitalopram Sales Market Share by Country in 2019
Figure 43. Europe Escitalopram Revenue Market Share by Country in 2019
Figure 44. Germany Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Escitalopram Market Share by Type in 2019
Figure 55. Europe Escitalopram Market Share by Application in 2019
Figure 56. Asia Pacific Escitalopram Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Escitalopram Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Escitalopram Sales Market Share by Region in 2019
Figure 59. Asia Pacific Escitalopram Revenue Market Share by Region in 2019
Figure 60. China Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Escitalopram Market Share by Type in 2019
Figure 83. Asia Pacific Escitalopram Market Share by Application in 2019
Figure 84. Latin America Escitalopram Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Escitalopram Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Escitalopram Sales Market Share by Country in 2019
Figure 87. Latin America Escitalopram Revenue Market Share by Country in 2019
Figure 88. Mexico Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Escitalopram Market Share by Type in 2019
Figure 95. Latin America Escitalopram Market Share by Application in 2019
Figure 96. Middle East and Africa Escitalopram Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Escitalopram Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Escitalopram Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Escitalopram Revenue Market Share by Country in 2019
Figure 100. Turkey Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Escitalopram Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Escitalopram Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Escitalopram Market Share by Type in 2019
Figure 107. Middle East and Africa Escitalopram Market Share by Application in 2019
Figure 108. North America Escitalopram Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Escitalopram Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Escitalopram Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Escitalopram Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Escitalopram Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Escitalopram Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Escitalopram Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Escitalopram Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Escitalopram Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Escitalopram Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
タブレット＆ペレットコーティングシステムの世界市場（～2026年） Tablet & pellets coating is among the traditional pharmaceutical processes which is still continuing with advanced machinery technologies. The major factors boosting the growth of tablet & pellet coating systems market are pharmaceutical industry growth, advancement in tablet coating market, increas…- ノートパソコン・タブレットPCの世界市場（～2026年） A tablet computer, commonly shortened to tablet, is a mobile device, typically with a mobile operating system and LCD touchscreen display processing circuitry, and a rechargeable battery in a single thin, flat package and a laptop, also called a notebook computer or simply a notebook, is a small, po…
- 内部鎮痛剤錠剤の世界市場（～2026年） Market Analysis and Insights: Global Internal Analgesic Tablet Market The global Internal Analgesic Tablet market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Internal Analgesic Tablet Scope and Market Size Internal Analge…
- 制酸薬の世界市場（～2026年） Market Analysis and Insights: Global Antacid Tablet Market The global Antacid Tablet market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Antacid Tablet Scope and Market Size Antacid Tablet market is segmented by Type, and …
- タブレットスクリーンプロテクターの世界市場（～2026年） Market Analysis and Insights: Global Tablet Screen Protectors Market The global Tablet Screen Protectors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tablet Screen Protectors Scope and Market Size Tablet Screen Prot…